Multi-Constrained Evolutionary Molecular Design Framework: An Interpretable Drug Design Method Combining Rule-Based Evolution and Molecular Crossover

• URL: http://arxiv.org/abs/2601.10110v1
• Date: Thu, 15 Jan 2026 06:37:07 GMT
• Title: Multi-Constrained Evolutionary Molecular Design Framework: An Interpretable Drug Design Method Combining Rule-Based Evolution and Molecular Crossover
• Authors: Shanxian Lin, Wei Xia, Yuichi Nagata, Haichuan Yang,
• Abstract summary: MCEMOL (Multi-Constrained Evolutionary Molecular Design Framework) is a molecular optimization approach integrating rule-based evolution with molecular crossover.<n>Unlike deep learning methods requiring large datasets and extensive training, our algorithm evolves efficiently from minimal starting molecules with low computational overhead.<n> Experimental results demonstrate that MCEMOL provides transparent design pathways through its evolutionary mechanism while generating valid, diverse, target-compliant molecules.
• Score: 11.76474263237491
• License: http://arxiv.org/licenses/nonexclusive-distrib/1.0/
• Abstract: This study proposes MCEMOL (Multi-Constrained Evolutionary Molecular Design Framework), a molecular optimization approach integrating rule-based evolution with molecular crossover. MCEMOL employs dual-layer evolution: optimizing transformation rules at rule level while applying crossover and mutation to molecular structures. Unlike deep learning methods requiring large datasets and extensive training, our algorithm evolves efficiently from minimal starting molecules with low computational overhead. The framework incorporates message-passing neural networks and comprehensive chemical constraints, ensuring efficient and interpretable molecular design. Experimental results demonstrate that MCEMOL provides transparent design pathways through its evolutionary mechanism while generating valid, diverse, target-compliant molecules. The framework achieves 100% molecular validity with high structural diversity and excellent drug-likeness compliance, showing strong performance in symmetry constraints, pharmacophore optimization, and stereochemical integrity. Unlike black-box methods, MCEMOL delivers dual value: interpretable transformation rules researchers can understand and trust, alongside high-quality molecular libraries for practical applications. This establishes a paradigm where interpretable AI-driven drug design and effective molecular generation are achieved simultaneously, bridging the gap between computational innovation and practical drug discovery needs.

Related papers

• $\text{M}^{2}$LLM: Multi-view Molecular Representation Learning with Large Language Models [59.125833618091846]
  We propose a multi-view framework that integrates three perspectives: the molecular structure view, the molecular task view, and the molecular rules view.<n>Experiments demonstrate that $textM2$LLM achieves state-of-the-art performance on multiple benchmarks across classification and regression tasks.
  arXiv  Detail & Related papers  (2025-08-12T05:46:47Z)
• AdaptMol: Adaptive Fusion from Sequence String to Topological Structure for Few-shot Drug Discovery [7.338199946027998]
  We present AdaptMol, a prototypical network integrating Adaptive multimodal fusion for representation.<n>This framework employs a dual-level attention mechanism to dynamically integrate global and local molecular features.<n>Experiments on three commonly used benchmarks under 5-shot and 10-shot settings demonstrate that AdaptMol achieves state-of-the-art performance.
  arXiv  Detail & Related papers  (2025-05-17T07:12:12Z)
• GraphXForm: Graph transformer for computer-aided molecular design [73.1842164721868]
  We present GraphXForm, a decoder-only graph transformer architecture, which is pretrained on existing compounds.<n>We evaluate it on various drug design tasks, demonstrating superior objective scores compared to state-of-the-art molecular design approaches.
  arXiv  Detail & Related papers  (2024-11-03T19:45:15Z)
• Many-Shot In-Context Learning for Molecular Inverse Design [56.65345962071059]
  Large Language Models (LLMs) have demonstrated great performance in few-shot In-Context Learning (ICL) We develop a new semi-supervised learning method that overcomes the lack of experimental data available for many-shot ICL. As we show, the new method greatly improves upon existing ICL methods for molecular design while being accessible and easy to use for scientists.
  arXiv  Detail & Related papers  (2024-07-26T21:10:50Z)
• Human-level molecular optimization driven by mol-gene evolution [5.409648262203544]
  This study introduces the Deep Genetic Modification Algorithm (DGMM), which brings structure modification to the level of medicinal chemists. A discrete variational autoencoder (D-VAE) is used in DGMM to encode molecules as quantization code, mol-gene, which incorporates deep learning into genetic algorithms for flexible structural optimization.
  arXiv  Detail & Related papers  (2024-06-13T01:06:03Z)
• MolTC: Towards Molecular Relational Modeling In Language Models [28.960416816491392]
  We propose a novel framework for Molecular inTeraction prediction following Chain-of-Thought (CoT) theory termed MolTC. Our experiments, conducted across various datasets involving over 4,000,000 molecular pairs, exhibit the superiority of our method over current GNN and LLM-based baselines.
  arXiv  Detail & Related papers  (2024-02-06T07:51:56Z)
• Advancing Drug Discovery with Enhanced Chemical Understanding via Asymmetric Contrastive Multimodal Learning [23.85388398199658]
  We introduce Asymmetric Contrastive Multimodal Learning (ACML) to enhance molecular understanding and accelerate advancements in drug discovery.<n>ACML harnesses the power of effective asymmetric contrastive learning to seamlessly transfer information from various chemical modalities to molecular graph representations.<n>We demonstrate the effectiveness of this framework through large-scale cross-modality retrieval and isomer discrimination tasks.
  arXiv  Detail & Related papers  (2023-11-11T01:58:45Z)
• Towards Predicting Equilibrium Distributions for Molecular Systems with Deep Learning [60.02391969049972]
  We introduce a novel deep learning framework, called Distributional Graphormer (DiG), in an attempt to predict the equilibrium distribution of molecular systems. DiG employs deep neural networks to transform a simple distribution towards the equilibrium distribution, conditioned on a descriptor of a molecular system.
  arXiv  Detail & Related papers  (2023-06-08T17:12:08Z)
• Accurate Machine Learned Quantum-Mechanical Force Fields for Biomolecular Simulations [51.68332623405432]
  Molecular dynamics (MD) simulations allow atomistic insights into chemical and biological processes. Recently, machine learned force fields (MLFFs) emerged as an alternative means to execute MD simulations. This work proposes a general approach to constructing accurate MLFFs for large-scale molecular simulations.
  arXiv  Detail & Related papers  (2022-05-17T13:08:28Z)
• Molecular Attributes Transfer from Non-Parallel Data [57.010952598634944]
  We formulate molecular optimization as a style transfer problem and present a novel generative model that could automatically learn internal differences between two groups of non-parallel data. Experiments on two molecular optimization tasks, toxicity modification and synthesizability improvement, demonstrate that our model significantly outperforms several state-of-the-art methods.
  arXiv  Detail & Related papers  (2021-11-30T06:10:22Z)
• Molecular Design in Synthetically Accessible Chemical Space via Deep Reinforcement Learning [0.0]
  We argue that existing generative methods are limited in their ability to favourably shift the distributions of molecular properties during optimization. We propose a novel Reinforcement Learning framework for molecular design in which an agent learns to directly optimize through a space of synthetically-accessible drug-like molecules.
  arXiv  Detail & Related papers  (2020-04-29T16:29:28Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.